MDL 19301
Alternative Names: MDL 16861Latest Information Update: 28 Nov 1994
At a glance
- Originator Aventis
- Class Nonsteroidal anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation